Efficacy and Safety of a Modified Intravenous Recombinant Tissue Plasminogen Activator Regimen in Chinese Patients with Acute Ischemic Stroke
Shuming Pan(XinHua Hospital), Xiangjun Chen(Fudan University), Jiafu Liu(XinHua Hospital), Hao-Jun Li(XinHua Hospital), Sa Shen(Shanghai Jiao Tong University), Lihua Dai(Shanghai Ship and Shipping Research Institute), Ming Liu
Journal of Stroke and Cerebrovascular Diseases
October 29, 2012
Cited by 16
Related Papers
Stroke in China: advances and challenges in epidemiology, prevention, and management
|The Lancet Neurology|2019|1.6k
China stroke surveillance report 2021
|Military Medical Research|2023|554
Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Patients with Sepsis: A Prospective Observational Study
|Mediators of Inflammation|2016|228